Astrana Health Inc

ASTH is trading under the 9-day EMA, 20-day EMA, and 50-day SMA, signaling a medium-term bearish tradable side. Short-term momentum and sentiment show no clear edge, so execution should be deferred, with trimming into rallies toward the EMA zone and 50-day SMA.

• ↑Q2 revenue $972.5M (+49% YoY) and EPS $0.40 vs $0.19 last year.
• ↑Net income $19.7M (+110% YoY) with full-year revenue guide of $3.8–4.1B.
• ↓Negative profitability factors highlight margin conversion risks.